Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Second Genome completes $5mm Series A financing; adds $6.5mm

Executive Summary

First-time backers Advanced Technology Ventures and Morgenthaler Ventures have led a $5mm Series A financing for personalized GI medicines start-up Second Genome Inc. (formerly PhyloTech). An executive from each VC contributes a board member. Ten other investors participated, including existing shareholders Wavepoint Ventures, Seraph Group, and individual seed backers.
Deal Industry
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies